Infectious Disease Drugs Market Size, Trends, Analysis, and Outlook By Disease (HIV, Influenza, Hepatitis, Tuberculosis, Malaria, Others), By Treatment (Antibacterial, Antiviral, Antiparasitic, Others), by Country, Segment, and Companies, 2024-2032
The global Infectious Disease Drugs market size is poised to register 7.3% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Infectious Disease Drugs market across By Disease (HIV, Influenza, Hepatitis, Tuberculosis, Malaria, Others), By Treatment (Antibacterial, Antiviral, Antiparasitic, Others)
The Infectious Disease Drugs Market is evolving with the increasing prevalence of antimicrobial resistance, emerging infectious threats, and global pandemics, as well as advancements in antimicrobial stewardship, drug development, and infection control strategies that address unmet medical needs and public health challenges. Infectious disease drugs encompass a diverse range of antimicrobial agents, antiviral therapies, and immunotherapies used to prevent, treat, and manage bacterial, viral, fungal, and parasitic infections in humans and animals, offering therapeutic options for acute infections, chronic diseases, and opportunistic pathogens. The market is driven by innovations in drug discovery, pharmacology, and molecular diagnostics that enable rapid pathogen identification, targeted therapy, and precision medicine approaches tailored to individual patient profiles and microbial susceptibilities. Further, the growing emphasis on infectious disease surveillance, outbreak preparedness, and vaccine development is driving market expansion, as governments, healthcare organizations, and pharmaceutical companies collaborate to address emerging threats, vaccine-preventable diseases, and neglected tropical infections. By 2030, the market is expected to witness further growth as stakeholders invest in novel antimicrobial agents, antiviral vaccines, and host-directed therapies that combat drug-resistant pathogens, enhance immune responses, and improve global health security, fostering innovation and collaboration in infectious disease research and therapeutics.
Infectious Disease Drugs Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Infectious Disease Drugs market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Infectious Disease Drugs survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Infectious Disease Drugs industry.
Key market trends defining the global Infectious Disease Drugs demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Infectious Disease Drugs Market Segmentation- Industry Share, Market Size, and Outlook to 2032
The Infectious Disease Drugs industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Infectious Disease Drugs companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Infectious Disease Drugs industry
Leading Infectious Disease Drugs companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Infectious Disease Drugs companies.
Infectious Disease Drugs Market Study- Strategic Analysis Review
The Infectious Disease Drugs market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
The Infectious Disease Drugs industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2032 in three case scenarios- low case, reference case, and high case scenarios.
Infectious Disease Drugs Country Analysis and Revenue Outlook to 2032
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2032. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2032.
North America Infectious Disease Drugs Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong healthcare infrastructure. Leading companies focus on new product launches in the changing environment. The US healthcare expenditure is expected to grow to $4.8 trillion in 2024 (around 3.7% growth in 2024), potentially driving demand for various Infectious Disease Drugs market segments. Similarly, Strong market demand is encouraging Canadian Infectious Disease Drugs companies to invest in niche segments. Further, as Mexico continues to strengthen its relations and invest in technological advancements, the Mexico Infectious Disease Drugs market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Infectious Disease Drugs Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Infectious Disease Drugs industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of vendors in identifying and leveraging new growth prospects positions the European Infectious Disease Drugs market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Infectious Disease Drugs Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Infectious Disease Drugs in Asia Pacific. In particular, China, India, and South East Asian Infectious Disease Drugs markets present a compelling outlook for 2032, acting as a magnet for both domestic and multinational vendors seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major countries in the APAC region.
Latin America Infectious Disease Drugs Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Infectious Disease Drugs Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Infectious Disease Drugs market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Infectious Disease Drugs.
Infectious Disease Drugs Market Company Profiles
The global Infectious Disease Drugs market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are AbbVie Inc, Bajaj Healthcare Ltd, Boehringer Ingelheim GmbH, F Hoffmann-La Roche Ltd, Gilead Sciences Inc, GlaxoSmithKline plc, Hookipa Pharma Inc, Johnson & Johnson, Merck & Co. Inc, Novartis AG, Sanofi SA, Takeda Pharmaceutical Company Ltd.
Recent Infectious Disease Drugs Market Developments
The global Infectious Disease Drugs market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Infectious Disease Drugs Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2032 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
By Disease
HIV
Influenza
Hepatitis
Tuberculosis
Malaria
Others
By Treatment
Antibacterial
Antiviral
Antiparasitic
Others
Geographical Segmentation:
AbbVie Inc
Bajaj Healthcare Ltd
Boehringer Ingelheim GmbH
F Hoffmann-La Roche Ltd
Gilead Sciences Inc
GlaxoSmithKline plc
Hookipa Pharma Inc
Johnson & Johnson
Merck & Co. Inc
Novartis AG
Sanofi SA
Takeda Pharmaceutical Company Ltd
Formats Available: Excel, PDF, and PPT
The Infectious Disease Drugs Market is evolving with the increasing prevalence of antimicrobial resistance, emerging infectious threats, and global pandemics, as well as advancements in antimicrobial stewardship, drug development, and infection control strategies that address unmet medical needs and public health challenges. Infectious disease drugs encompass a diverse range of antimicrobial agents, antiviral therapies, and immunotherapies used to prevent, treat, and manage bacterial, viral, fungal, and parasitic infections in humans and animals, offering therapeutic options for acute infections, chronic diseases, and opportunistic pathogens. The market is driven by innovations in drug discovery, pharmacology, and molecular diagnostics that enable rapid pathogen identification, targeted therapy, and precision medicine approaches tailored to individual patient profiles and microbial susceptibilities. Further, the growing emphasis on infectious disease surveillance, outbreak preparedness, and vaccine development is driving market expansion, as governments, healthcare organizations, and pharmaceutical companies collaborate to address emerging threats, vaccine-preventable diseases, and neglected tropical infections. By 2030, the market is expected to witness further growth as stakeholders invest in novel antimicrobial agents, antiviral vaccines, and host-directed therapies that combat drug-resistant pathogens, enhance immune responses, and improve global health security, fostering innovation and collaboration in infectious disease research and therapeutics.
Infectious Disease Drugs Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Infectious Disease Drugs market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Infectious Disease Drugs survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Infectious Disease Drugs industry.
Key market trends defining the global Infectious Disease Drugs demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Infectious Disease Drugs Market Segmentation- Industry Share, Market Size, and Outlook to 2032
The Infectious Disease Drugs industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Infectious Disease Drugs companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Infectious Disease Drugs industry
Leading Infectious Disease Drugs companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Infectious Disease Drugs companies.
Infectious Disease Drugs Market Study- Strategic Analysis Review
The Infectious Disease Drugs market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
- Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
- Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
- Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
- Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
The Infectious Disease Drugs industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2032 in three case scenarios- low case, reference case, and high case scenarios.
Infectious Disease Drugs Country Analysis and Revenue Outlook to 2032
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2032. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2032.
North America Infectious Disease Drugs Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong healthcare infrastructure. Leading companies focus on new product launches in the changing environment. The US healthcare expenditure is expected to grow to $4.8 trillion in 2024 (around 3.7% growth in 2024), potentially driving demand for various Infectious Disease Drugs market segments. Similarly, Strong market demand is encouraging Canadian Infectious Disease Drugs companies to invest in niche segments. Further, as Mexico continues to strengthen its relations and invest in technological advancements, the Mexico Infectious Disease Drugs market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Infectious Disease Drugs Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Infectious Disease Drugs industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of vendors in identifying and leveraging new growth prospects positions the European Infectious Disease Drugs market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Infectious Disease Drugs Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Infectious Disease Drugs in Asia Pacific. In particular, China, India, and South East Asian Infectious Disease Drugs markets present a compelling outlook for 2032, acting as a magnet for both domestic and multinational vendors seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major countries in the APAC region.
Latin America Infectious Disease Drugs Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Infectious Disease Drugs Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Infectious Disease Drugs market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Infectious Disease Drugs.
Infectious Disease Drugs Market Company Profiles
The global Infectious Disease Drugs market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are AbbVie Inc, Bajaj Healthcare Ltd, Boehringer Ingelheim GmbH, F Hoffmann-La Roche Ltd, Gilead Sciences Inc, GlaxoSmithKline plc, Hookipa Pharma Inc, Johnson & Johnson, Merck & Co. Inc, Novartis AG, Sanofi SA, Takeda Pharmaceutical Company Ltd.
Recent Infectious Disease Drugs Market Developments
The global Infectious Disease Drugs market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Infectious Disease Drugs Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2032 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
- Pricing Analysis
- Value Chain Analysis
- SWOT Profile
- Market Dynamics- Trends, Drivers, Challenges
- Porter’s Five Forces Analysis
- Macroeconomic Impact Analysis
- Case Scenarios- Low, Base, High
By Disease
HIV
Influenza
Hepatitis
Tuberculosis
Malaria
Others
By Treatment
Antibacterial
Antiviral
Antiparasitic
Others
Geographical Segmentation:
- North America (3 markets)
- Europe (6 markets)
- Asia Pacific (6 markets)
- Latin America (3 markets)
- Middle East Africa (5 markets)
AbbVie Inc
Bajaj Healthcare Ltd
Boehringer Ingelheim GmbH
F Hoffmann-La Roche Ltd
Gilead Sciences Inc
GlaxoSmithKline plc
Hookipa Pharma Inc
Johnson & Johnson
Merck & Co. Inc
Novartis AG
Sanofi SA
Takeda Pharmaceutical Company Ltd
Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY
1.1 Infectious Disease Drugs Market Overview and Key Findings, 2024
1.2 Infectious Disease Drugs Market Size and Growth Outlook, 2021- 2030
1.3 Infectious Disease Drugs Market Growth Opportunities to 2030
1.4 Key Infectious Disease Drugs Market Trends and Challenges
1.4.1 Infectious Disease Drugs Market Drivers and Trends
1.4.2 Infectious Disease Drugs Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Infectious Disease Drugs Companies
2. INFECTIOUS DISEASE DRUGS MARKET SIZE OUTLOOK TO 2030
2.1 Infectious Disease Drugs Market Size Outlook, USD Million, 2021- 2030
2.2 Infectious Disease Drugs Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. INFECTIOUS DISEASE DRUGS MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. INFECTIOUS DISEASE DRUGS MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Disease
HIV
Influenza
Hepatitis
Tuberculosis
Malaria
Others
By Treatment
Antibacterial
Antiviral
Antiparasitic
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Infectious Disease Drugs Market, 2025
5.2 Asia Pacific Infectious Disease Drugs Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Infectious Disease Drugs Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Infectious Disease Drugs Market, 2025
5.5 Europe Infectious Disease Drugs Market Size Outlook by Type, 2021- 2030
5.6 Europe Infectious Disease Drugs Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Infectious Disease Drugs Market, 2025
5.8 North America Infectious Disease Drugs Market Size Outlook by Type, 2021- 2030
5.9 North America Infectious Disease Drugs Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Infectious Disease Drugs Market, 2025
5.11 South America Pacific Infectious Disease Drugs Market Size Outlook by Type, 2021- 2030
5.12 South America Infectious Disease Drugs Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Infectious Disease Drugs Market, 2025
5.14 Middle East Africa Infectious Disease Drugs Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Infectious Disease Drugs Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Infectious Disease Drugs Market Size Outlook and Revenue Growth Forecasts
6.2 US Infectious Disease Drugs Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Infectious Disease Drugs Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Infectious Disease Drugs Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Infectious Disease Drugs Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Infectious Disease Drugs Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Infectious Disease Drugs Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Infectious Disease Drugs Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Infectious Disease Drugs Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Infectious Disease Drugs Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Infectious Disease Drugs Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Infectious Disease Drugs Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Infectious Disease Drugs Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Infectious Disease Drugs Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Infectious Disease Drugs Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Infectious Disease Drugs Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Infectious Disease Drugs Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Infectious Disease Drugs Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Infectious Disease Drugs Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Infectious Disease Drugs Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Infectious Disease Drugs Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Infectious Disease Drugs Industry Drivers and Opportunities
7. INFECTIOUS DISEASE DRUGS MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. INFECTIOUS DISEASE DRUGS COMPANY PROFILES
8.1 Profiles of Leading Infectious Disease Drugs Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
AbbVie Inc
Bajaj Healthcare Ltd
Boehringer Ingelheim GmbH
F Hoffmann-La Roche Ltd
Gilead Sciences Inc
GlaxoSmithKline plc
Hookipa Pharma Inc
Johnson & Johnson
Merck & Co. Inc
Novartis AG
Sanofi SA
Takeda Pharmaceutical Company Ltd.
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
1.1 Infectious Disease Drugs Market Overview and Key Findings, 2024
1.2 Infectious Disease Drugs Market Size and Growth Outlook, 2021- 2030
1.3 Infectious Disease Drugs Market Growth Opportunities to 2030
1.4 Key Infectious Disease Drugs Market Trends and Challenges
1.4.1 Infectious Disease Drugs Market Drivers and Trends
1.4.2 Infectious Disease Drugs Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Infectious Disease Drugs Companies
2. INFECTIOUS DISEASE DRUGS MARKET SIZE OUTLOOK TO 2030
2.1 Infectious Disease Drugs Market Size Outlook, USD Million, 2021- 2030
2.2 Infectious Disease Drugs Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. INFECTIOUS DISEASE DRUGS MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. INFECTIOUS DISEASE DRUGS MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Disease
HIV
Influenza
Hepatitis
Tuberculosis
Malaria
Others
By Treatment
Antibacterial
Antiviral
Antiparasitic
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Infectious Disease Drugs Market, 2025
5.2 Asia Pacific Infectious Disease Drugs Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Infectious Disease Drugs Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Infectious Disease Drugs Market, 2025
5.5 Europe Infectious Disease Drugs Market Size Outlook by Type, 2021- 2030
5.6 Europe Infectious Disease Drugs Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Infectious Disease Drugs Market, 2025
5.8 North America Infectious Disease Drugs Market Size Outlook by Type, 2021- 2030
5.9 North America Infectious Disease Drugs Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Infectious Disease Drugs Market, 2025
5.11 South America Pacific Infectious Disease Drugs Market Size Outlook by Type, 2021- 2030
5.12 South America Infectious Disease Drugs Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Infectious Disease Drugs Market, 2025
5.14 Middle East Africa Infectious Disease Drugs Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Infectious Disease Drugs Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Infectious Disease Drugs Market Size Outlook and Revenue Growth Forecasts
6.2 US Infectious Disease Drugs Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Infectious Disease Drugs Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Infectious Disease Drugs Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Infectious Disease Drugs Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Infectious Disease Drugs Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Infectious Disease Drugs Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Infectious Disease Drugs Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Infectious Disease Drugs Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Infectious Disease Drugs Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Infectious Disease Drugs Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Infectious Disease Drugs Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Infectious Disease Drugs Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Infectious Disease Drugs Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Infectious Disease Drugs Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Infectious Disease Drugs Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Infectious Disease Drugs Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Infectious Disease Drugs Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Infectious Disease Drugs Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Infectious Disease Drugs Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Infectious Disease Drugs Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Infectious Disease Drugs Industry Drivers and Opportunities
7. INFECTIOUS DISEASE DRUGS MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. INFECTIOUS DISEASE DRUGS COMPANY PROFILES
8.1 Profiles of Leading Infectious Disease Drugs Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
AbbVie Inc
Bajaj Healthcare Ltd
Boehringer Ingelheim GmbH
F Hoffmann-La Roche Ltd
Gilead Sciences Inc
GlaxoSmithKline plc
Hookipa Pharma Inc
Johnson & Johnson
Merck & Co. Inc
Novartis AG
Sanofi SA
Takeda Pharmaceutical Company Ltd.
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
